Pharmacologic vitreolysis - Premise and promise of the first decade

Retina

Volumn 29, Issue 7, 2009, Pages 871-874

  Sebag, Jerry ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VMR Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; DISPASE; HYALURONIDASE; ISOENZYME; MICROPLASMIN; N ACETYLGALACTOSAMINE 4 SULFATASE; NATTOKINASE; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DIABETIC RETINOPATHY; EDITORIAL; EYE CARE; EYE DISEASE; GENETIC PREDISPOSITION; HUMAN; LIQUEFACTION; NONHUMAN; PHARMACOLOGIC VITREOLYSIS; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HOLE; RETROLENTAL FIBROPLASIA; VITREORETINOPATHY; VITREOSCHISIS; VITREOUS BODY DETACHMENT; VITREOUS HEMORRHAGE;

FIBRINOLYTIC AGENTS; HUMANS; OPHTHALMOLOGY; RETINAL DISEASES; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 68249124041     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181ac7b3c     Document Type: Editorial

References (43)

1. Sebag J. Pharmacologic vitreolysis. Retina 1998;18:1-3.
2. Sebag J. The Vitreous-Structure, Function, and Pathobiology. New York, NY: Springer-Verlag; 1989.
3. Sebag J, Yee KMP. Vitreous-from biochemistry to clinical relevance. In: William T, Edward AJ, eds. Duane's Foundations of Clinical Ophthalmology. Vol.1. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:chap 16.
4. Jalkh A, Takahashi M, Topilow HW, et al. Prognostic value of vitreous findings in diabetic retinopathy. Arch Ophthalmol 1982;100:432-434. (Pubitemid 12183555)
5. Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology 1990;97:889-891. (Pubitemid 20217938)
6. Krebs I, Brannath W, Glittenberg K, Zeiler F, Sebag J, Binder S. Posterior vitreo-macular adhesion: a potential risk factor for exudative age-related macular degeneration. Am J Ophthalmol 2007;144:741-746. (Pubitemid 47614954)
7. Robison C, Krebs I, Binder S, et al. Vitreo-macular adhesion in active and end-stage age-related macular degeneration. Am J Ophthalmol. 2009 Mar 26 [Epub ahead of print].
8. Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol 2004;242:690-698. (Pubitemid 39242846)
9. Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol 2008;246:329-332.
10. Schwartz SD, Alexander R, Hiscott P, Gregor ZJ. Recognition of vitreoschisis in proliferative diabetic retinopathy. Ophthalmology 1996;103:323-328.
11. Sebag J, Gupta P, Rosen R, Garcia P, Sadun AA. Macular holes and macular pucker: the role of vitreoschisis as imaged by optical coherence tomography-scanning laser ophthalmoscopy. Trans Am Ophthalmol Soc 2007;105:121-131. (Pubitemid 352031802)
12. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001;108:1902-1905.
13. Sakuma T, Tanaka M, Inoue M, Mizota A, Souri M, Ichinose A. Efficacy of autologous plasmin for idiopathic macular hole surgery. Eur J Ophthalmol 2005;15:787-794. (Pubitemid 43074708)
14. Wu WC, Drenser KA, Lai M, Capone A, Trese M. Plasmin enzyme-assisted vitrectomy for primary and reoperated eyes with stage 5 retinopathy of prematurity. Retina 2008;28(3 suppl):S75-S80. (Pubitemid 351644429)
15. Wu WC, Drenser KA, Capone A, Williams GA, Trese MT. Plasmin enzyme-assisted vitreoretinal surgery in congenital X-linked retinoschisis: surgical techniques based on a new classification system. Retina 2007;27:1079-1085. (Pubitemid 350304011)
16. Lariukhina GM, Ziangirova GG. Experimental enzymatic vitreolysis. Vestn Oftalmol 1977;6:77-79.
17. Zagórski Z. Effect of enzymatic vitreolysis on the absorption of experimental vitreous hemorrhage. Preliminary report. Klin Oczna 1983;85:197-199.
18. Hesse L, Nebeling B, Schroeder B, Heller G, Kroll P. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res 2000;70:31-39. (Pubitemid 30046872)
19. Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993;111:849-854. (Pubitemid 23170602)
20. Uemura A, Nakamura M, Kachi S, et al. Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy. Arch Ophthalmol 2005;123:209-213. (Pubitemid 40189708)
21. Sakuma T, Tanaka M, Mizota A, Inoue J, Pakola S. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci 2005;46:3295-3299. (Pubitemid 44264318)
22. Sebag J, Ansari RR, Suh KI. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefes Arch Clin Exp Ophthalmol 2007;245:576-580. (Pubitemid 46477319)
23. Takano A, Hirata A, Ogasawara K, et al. Posterior vitreous detachment induced by nattokinase (subtilisin NAT): a novel enzyme for pharmacologic vitreolysis. Invest Ophthalmol Vis Sci 2006;47:2075-2079. (Pubitemid 46768291)
24. Hageman GS, Russell SR. Chondroitinase-mediated disinsertion of the primate vitreous body. Invest Ophthalmol Vis Sci 1994;35:1260.
25. Bishop PN, McLeod D, Reardon A. Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel. Invest Ophthalmol Vis Sci 1999;40:2173-2178. (Pubitemid 29418369)
26. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase. Retina 1998;18:7-15.
27. Wang F, Wang Z, Sun X, Wang F, Xu X, Zhang X. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci 2004;45:3286-3290. (Pubitemid 39121868)
28. Hikichi T, Kado M, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina 2000;20:195-198. (Pubitemid 30395716)
29. Wang ZL, Zhang X, Xu X, Sun XD, Wang F. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy. Retina 2005;25:38-43. (Pubitemid 40250406)
30. Nickerson CS. Engineering the Mechanical Properties of Ocular Tissues. Thesis, Doctor of Philosophy, California Institute of Technology, 2006.
31. Oliveira LB, Meyer CH, Kumar J, et al. RGD peptide-assisted vitrectomy to facilitate induction of a posterior vitreous detachment: a new principle in pharmacologic vitreolysis. Curr Eye Res 2002;25:333-340. (Pubitemid 36724163)
32. Shires TK, Faeth JA, Pulido JS. Nonenzymatic glycosylation of vitreous proteins in vitro and in the streptozotocin-treated diabetic rat. Retina 1990;10:153-158.
33. Sebag J, Buckingham B, Charles MA, Reiser K. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol 1992;110:1472-1476.
34. Sebag J, Nie S, Reiser K, Charles MA, Yu NT. Raman spectroscopy of human vitreous in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1994;35:2976-2980. (Pubitemid 24186399)
35. Stitt AW, Moore JE, Sharkey JA, et al. Advanced glycation end products in vitreous: structural and functional implications for diabetic vitreopathy. Invest Ophthalmol Vis Sci 1998;39:2517-2523.
36. Sebag J. Abnormalities of human vitreous structure in diabetes. Graefes Arch Clin Exp Ophthalmol 1993;231:257-260. (Pubitemid 23197127)
37. Sebag J. Diabetic vitreopathy. Ophthalmology 1996;103:205-206.
38. Kroll P, Rodrigues EB, Hoerle S. Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica 2007;221:78-94. (Pubitemid 46465433)
39. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR; Vitrase for Vitreous Hemorrhage Study Groups. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005;140:573-584.
40. Azzolini C, D'Angelo A, Maestranzi G, et al. Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol 2004;138:560-566. (Pubitemid 39420482)
41. Sebag J. Is pharmacologic vitreolysis brewing? Retina 2002;22:1-3.
42. Quiram PA, Leverenz VR, Baker RM, Dang L, Giblin FJ, Trese MT. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina 2007;27:1090-1096. (Pubitemid 350304013)
43. Stefansson E. Letter to the editor. Retina 2008;28:1175-1176.